April 28th 2022
Experts share insight on the evolving treatment armamentarium for myeloproliferative neoplasms.
April 26th 2022
Dr. Michael Atkins and Dr. Evan Lipson discuss the state of metastatic melanoma, contemporary and emerging treatment strategies, and break down a specific patient profile. Their conversation touches on the pros and cons of different treatment strategies for newly diagnosed patients as well as second- and third-line treatment strategies. Dr. Atkins and Dr. Lipson also take time to provide their personal experiences, preferences, and thoughts on prospects involving the treatment and management of metastatic melanoma.
April 15th 2022
Experts in the field of differentiated thyroid cancer highlight recent advances in treatment by reviewing two real-world patient scenarios.
April 15th 2022
Expert oncologists share updates on the testing and treatment of molecular alterations in advanced non-small cell lung cancer.
April 7th 2022
Shared insight on the evolving treatment armamentarium for metastatic CRPC and how expert physicians are optimizing care.
April 5th 2022
A discussion on recent advances in the treatment of advanced renal cell carcinoma and their impact on clinical practice, illustrated by real-world patient profiles.
April 1st 2022
Expert perspectives on historical and novel treatment strategies for patients diagnosed with chronic graft-versus-host disease.
March 21st 2022
Centering discussion on patient profiles, expert panelists review recent advances in the treatment of renal cell carcinoma and their impact on clinical practice.
March 15th 2022
This OncLive Insights features a medical oncologist and gynecologic oncologist who share their thoughts on the selection of first-line and subsequent therapy in advanced endometrial cancer. They discuss treatment strategies and novel therapeutics that may improve health outcomes in patients with the disease.
March 4th 2022
Expert gynecologic oncologists provide a discussion on the care of patients with endometrial carcinoma.
February 3rd 2022
Insight regarding the utilization of antibody-drug conjugate therapy to treat relapsed/refractory advanced bladder cancer.
January 28th 2022
Nicole Lamanna, MD, and Nirav N. Shah, MD, discuss the use of BTK inhibitors as targeted therapy for chronic lymphocytic leukemia and recent advancements.
January 26th 2022
This OncLive Insights features three immune thrombocytopenia experts who share their approach to treating different patient populations, considerations when selecting treatments, and emerging therapies for this condition.
January 25th 2022
Recommendations for assessing and treating patients with relapsed/refractory B-cell ALL based on more recent data presented at ASH 2021.
December 23rd 2021
Expert oncologists navigate the evolving treatment landscape of advanced or metastatic urothelial carcinoma.
December 23rd 2021
An overview of the role of currently-available and emerging BCMA-targeting therapies in the treatment landscape for multiple myeloma.
December 21st 2021
David Gerber, MD, and Steven Vernino, PhD, provide a discussion on Lambert-Eaton Myasthenic Syndrome (LEMS), its association with small cell lung cancer, and the available treatment options.
December 14th 2021
Experts come together to share their perspective on the paradigm of previously treated Ph+ chronic myeloid leukemia.
December 13th 2021
Approaches to planning treatment for patients with newly diagnosed chronic lymphocytic leukemia, as recommended by healthcare professionals from Memorial Sloan Kettering Cancer Center.